ERIS LIFESCIENCES
Back to Income Statement
|
ERIS LIFESCIENCES Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹392 Cr | ₹3,822 Cr | ₹406 Cr | ₹355 Cr | ₹296 Cr |
What is the latest Consolidated Net Profit of ERIS LIFESCIENCES ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹392 Cr |
| Mar2024 | ₹3,822 Cr |
| Mar2023 | ₹406 Cr |
| Mar2022 | ₹355 Cr |
| Mar2021 | ₹296 Cr |
How is Consolidated Net Profit of ERIS LIFESCIENCES Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹392 Cr | -89.74 | |
| Mar2024 | ₹3,822 Cr | 841.01 | |
| Mar2023 | ₹406 Cr | 14.35 | |
| Mar2022 | ₹355 Cr | 19.78 | |
| Mar2021 | ₹296 Cr | - | |
Compare Consolidated Net Profit of peers of ERIS LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ERIS LIFESCIENCES | ₹18,423.3 Cr | -0.6% | -2.1% | -0% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹406,603.0 Cr | -5.6% | -2.5% | -1.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹155,485.0 Cr | -2.6% | -8.7% | 1.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹135,009.0 Cr | -7.2% | -8% | 27.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,628.0 Cr | -6.5% | -5.4% | 3.9% | Stock Analytics | |
| CIPLA | ₹96,400.8 Cr | -4.1% | -11.5% | -19% | Stock Analytics | |
ERIS LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ERIS LIFESCIENCES | -0.6% |
-2.1% |
-0% |
| SENSEX | -1% |
-10.9% |
-6% |
You may also like the below Video Courses